Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autotransplants in leukemia: current state, future progress.

R P Gale1, A Butturini, P Reizenstein

  • 1Department of Medicine, UCLA School of Medicine 90024-1678.

Leukemia Research
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Habitability of Present-Day Martian Subsurface for Earth-Like Methanogens.

Astrobiology·2025
Same author

Origin, accumulation and fate of dissolved organic matter in an extreme hypersaline shallow lake.

Water research·2022
Same author

Dissolved organic matter in a tropical saline-alkaline lake of the East African Rift Valley.

Water research·2020
Same author

Effect of Cytotoxic Cells on Minimal Residual Leukemia.

Leukemia & lymphoma·2016
Same author

Can Long-Term Bone Marrow Culture Eliminate Leukemia Cells?

Leukemia & lymphoma·2016
Same author

Hydrological conditions control in situ DOM retention and release along a Mediterranean river.

Water research·2016
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

Autotransplants for leukemia remain debated. This study questions if intensive therapy improves leukemia cures, considering transplant biases, relapse origins, stem cell sources, and alternative intensive treatments.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Immunology

Background:

  • Autotransplantation in leukemia treatment is controversial.
  • The rationale and efficacy of autotransplants are frequently questioned in scientific literature.

Purpose of the Study:

  • To critically evaluate the evidence supporting intensive therapy in leukemia cures.
  • To investigate potential biases, such as subject selection and time-to-treatment censoring, affecting autotransplant outcomes.
  • To explore the origins of leukemia relapse post-autotransplant and compare outcomes across different hematopoietic stem cell sources.

Main Methods:

  • Review and analysis of existing data on autotransplantation in leukemia.
  • Examination of factors influencing treatment intensity and cure rates.

Related Experiment Videos

  • Investigation into the sources of leukemia relapse (endogenous vs. graft-derived).
  • Comparative analysis of outcomes based on hematopoietic stem cell source.
  • Assessment of the role of immune-mediated mechanisms in preventing relapse.
  • Evaluation of non-transplant intensive therapy options.

    • Main Results:

    • Data regarding the effectiveness of intensified therapy in increasing leukemia cures are critically assessed.
    • Potential biases in subject selection and time-to-treatment censoring that may confound autotransplant results are examined.
    • The study investigates whether leukemia relapse originates from residual leukemia cells within the patient or from the transplanted graft.
    • Outcomes associated with autotransplants utilizing different hematopoietic stem cell sources are compared.
    • The likelihood of immune-mediated anti-leukemia effects contributing to relapse prevention after autotransplantation is evaluated.
    • The feasibility and outcomes of delivering intensive therapy without autotransplantation are considered.

    Conclusions:

    • The study concludes that the benefits of autotransplantation in leukemia require further rigorous investigation.
    • Addressing biases and understanding relapse mechanisms are crucial for optimizing leukemia treatment strategies.
    • Alternative intensive therapeutic approaches should be explored to potentially achieve comparable outcomes without autotransplantation.